Doug VanOort | Chief Executive Officer |
Sharon Virag | Chief Financial Officer |
George Cardoza | President, Pharma Services Division |
Bill Bonello | Chief Strategy & Corporate Development Officer & Director of Investor Relations |
Kevin Ellich | Craig-Hallum |
Puneet Souda | SVB Leerink |
Brian Weinstein | William Blair |
John Hsu | Raymond James |
Steve Unger | Needham |
Joe Munda | First Analysis |
Bruce Jackson | The Benchmark Company |
Good day, ladies and gentlemen, and welcome to the NeoGenomics Second Quarter 2019 Earnings Call. All lines have been placed in the listen-only mode and there will be question-and-answer session after the presentation. [Operator Instructions]
At this time, it's my pleasure to turn the floor over to Mr. Doug VanOort, Chief Executive Officer.